Endometrial cancer is a growing concern both in Australia and internationally. Over the last period of time, the number of new cases diagnosed every year have skyrocketed, doubling within a decade.
What is Endometrial cancer?
Endometrial cancer is a type of cancer of the uterus, or womb. It specifically begins in the inner lining of the uterus, which is known as the endometrium. Surprisingly, it is the most common form of uterine cancer, making up an overwhelming 95% of all uterine cancer cases diagnosed annually.
Why is endometrial cancer a problem?
The numbers speak for themselves. Each year, more than 3,000 Australian women and 700 New Zealand women receive this life-altering diagnosis. This alarming growth rate is not just a statistic but represents thousands of women whose lives have been altered forever. Endometrial cancer is the most common type of cancer that can affect parts of the female reproductive tract, yet is generally very under-recognised by both the public and in research.
Watch Professor Linda Mileshkin, Chair of the EDEN Initiative & Medical Oncologist speak about endometrial cancer:
Flattening the endometrial cancer curve
Research is one of the best tools for curbing the growth of endometrial cancer. Through targeted research, understanding of this disease can be deepened, and new treatment methods which could potentially save lives can be discovered. But research isn't just about finding a cure; it's about improving the quality of life for those living with endometrial cancer and ensuring they have access to the best care possible.
ANZGOG’s EDEN Initiative is leading the charge to reduce the number of new endometrial cancer cases and improve the lived experiences of women diagnosed with the disease. We are bringing together expert endometrial cancer doctors, nurses, and allied health professionals, passionate researchers, and, most importantly, women with a lived experience to focus on:
- Prevention: understanding risk factors
- Early diagnosis: symptom awareness, identification of reliable screening options
- Better treatments: including personalising treatment options to specific patient needs.
- Improved outcomes: including better management of side-effects, well-being needs, and best practise for ongoing follow-up with doctors.
- More research: including that to identify new drugs and drug targets.
- New clinical trials: and better access for patients all around Australia and New Zealand, no matter where they live.
- Giving endometrial cancer patients a voice.
Research for endometrial cancer is notoriously underfunded, despite how common it is becoming in the community. They need support from you, from fundraisers, advocates, and the community. Donate now and create a brighter future for thousands of women.
